Skip to content
Screener

NeoGenomics NEO Reportable Segment — Other Nonoperating Income (Expense)

Similar metrics at other companies

Dollar Tree logo
DLTRReportable Segment — Other Nonoperating Income (Expense)
$5.4M-91.2%
comScore logo
SCORReportable Segment — Other Nonoperating Income (Expense)
-$717K-108%
Rimini Street, Inc. logo
RMNIReportable Segment — Other Nonoperating Income (Expense)
-$1.24M-1,510%
Nextpower Inc. logo
NXTReportable Segment — Other Nonoperating Income (Expense)
$6.39M+11.9%
ITG
ITGRReportable Segment — Other Nonoperating Income (Expense)
-$13.3M-1,411%
Global Industrial logo
GICReportable Segment — Other Nonoperating Income (Expense)
$100K+200%

Other financials

Income statement

See full
Revenue$201.7M+11.2%
Gross profit$91.9M+18.9%
Operating income-$9.8M+79.5%
Net income$2.2M+105%
EPS (diluted)$0.02+106%

Balance sheet

See full
Cash & equivalents$145.5M-5.9%
Total debt$448.4M+534%
Total equity$785.7M-8.0%
Total assets$1.4B-3.0%

Cash flow

See full
Operating cash flow$20.0M-1.8%
CapEx$8.2M+30.0%
Free cash flow-$13.1M+56.0%

Valuation

See full
Market cap$2B+182%
Enterprise value$2.3B+268%
P/S2.6×+1.6×

Profitability

See full
Gross margin43.9%0.0pp
Operating margin-8.9%-2.8pp
Net margin-6.8%-2.4pp
FCF margin-4.9%

Returns & leverage

See full
Return on equity-6.3%-2.0pp
Debt / equity0.6×+0.5×
Current ratio3.6×-0.3×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001077183-26-000059
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Loss from operations(9,771)(47,628)(28,012)(75,453)
Interest income1,2142,2632,4875,984
Interest expense(781)(933)(1,379)(2,551)
Other (expense) income(17)482(29)547
Gain on extinguishment of debt (Note 6)11,18111,181
Income (loss) before taxes1,826(45,816)(15,752)(71,473)
Income tax benefit412724884458
Net income (loss)$2,238$(45,092)$(14,868)$(71,015)

Item 1. Financial Statements (unaudited)

FAQ

What is NeoGenomics's reportable segment — other nonoperating income (expense)?
NeoGenomics (NEO) reported reportable segment — other nonoperating income (expense) of -$17K in Q2 2026.
How has NeoGenomics's reportable segment — other nonoperating income (expense) changed year-over-year?
NeoGenomics's reportable segment — other nonoperating income (expense) decreased by 103.5% year-over-year, from $482K to -$17K.
What is the long-term trend for NeoGenomics's reportable segment — other nonoperating income (expense)?
Over 3 years (2022 to 2025), NeoGenomics's reportable segment — other nonoperating income (expense) has grown at a 11.6% compound annual growth rate (CAGR), from -$213K to $296K.
What does reportable segment — other nonoperating income (expense) mean?
This captures miscellaneous financial gains or losses that are not directly related to the core operational activities of the reportable segment. It includes items such as foreign exchange fluctuations, minor asset disposals, or other peripheral financial activities.

Ask your AI about NeoGenomics's reportable segment — other nonoperating income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude